Loyal
PrivateLast Round
Series C
Feb 11, 2026
Est. Valuation
$425M
Total Funding Raised
$205M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Loyal is a clinical-stage veterinary medicine company that develops drugs intended to extend the healthspan and lifespan of dogs by delaying the onset of age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B2C
Customer Profile
Subscription SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Loyal Comparables
Compare Loyal with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Animal Biosciences, Inc. | 79% | |
| Gallant | 63% | |
| Zoetis Inc. | 61% |
Loyal Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 11, 2026 | ||||
| Series B Extension | Feb 26, 2025 | ||||
| Series B | Mar 21, 2024 | ||||
| Series A | Sep 23, 2021 | ||||
| Seed | Jan 1, 2020 |
Loyal Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bain Capital Ventures | Series B Extension, Series B |
| Khosla Ventures | Series B, Seed, Series B Extension, Series A |
| age1 | Series C |
| Todd & Rahul Capital | Series B |
| Collaborative Fund | Series B, Series A, Seed, Series B Extension |
| First Round Capital | Series B, Series A, Seed, Series B Extension |
| BoxGroup | Series B, Series A, Seed, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 45% MoM.
- Feb 11, 2026
$100M round raised.
Recent news
Latest coverage and updates
- is_developingAug 29, 2026
Loyal is developing longevity and lifespan-extension drugs for dogs on Sep 18th '26.
Loyal Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Loyal's valuation, stock price, and market status.
Is Loyal a public or private company?
Loyal is a private company.
What is the current stock price of Loyal?
Loyal is a private company with no public stock price. No recent secondary market data is available.
How much is Loyal worth (valuation)?
Loyal's valuation is estimated at $425.0M based on funding round data.
Can I buy Loyal stock?
Loyal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Loyal's last funding round?
Loyal's most recent funding round was Series C on February 26, 2025.
Who are the main investors in Loyal?
Key investors in Loyal include Bain Capital Ventures, Khosla Ventures, age1, Collaborative Fund, Valor Equity Partners.
Will Loyal IPO soon?
No public IPO plans have been announced for Loyal.
How can I track Loyal secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Loyal's secondary market activity and sign up for updates.